Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women
- Resource Type
- Authors
- Safaa Ahmed; David B. Seifer; Howard Minkoff; Zaher Merhi; Oumar Kuzbari; Muhammad Faisal Aslam
- Source
- Fertility and Sterility. 95:1790-1793
- Subject
- Adult
Anti-Mullerian Hormone
medicine.medical_specialty
endocrine system diseases
Matched-Pair Analysis
medicine.medical_treatment
MULLERIAN-INHIBITING SUBSTANCE
Article
Young Adult
Neurotrophic factors
Neoplasms
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
otorhinolaryngologic diseases
Humans
Medicine
Young adult
Ovarian reserve
Brain-derived neurotrophic factor
Chemotherapy
biology
business.industry
Brain-Derived Neurotrophic Factor
Obstetrics and Gynecology
Cancer
Anti-Müllerian hormone
Middle Aged
medicine.disease
Endocrinology
Premenopause
nervous system
Reproductive Medicine
biology.protein
Female
business
- Language
- ISSN
- 0015-0282
Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and müllerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.